Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cavitation Technologies (CVAT) Research & Development (2016 - 2025)

Cavitation Technologies' Research & Development history spans 16 years, with the latest figure at $4000.0 for Q4 2025.

  • On a quarterly basis, Research & Development fell 75.0% to $4000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $82000.0, a 67.35% increase, with the full-year FY2025 number at $95000.0, up 55.74% from a year prior.
  • Research & Development hit $4000.0 in Q4 2025 for Cavitation Technologies, down from $7000.0 in the prior quarter.
  • Over the last five years, Research & Development for CVAT hit a ceiling of $42000.0 in Q1 2025 and a floor of $1000.0 in Q2 2022.
  • Historically, Research & Development has averaged $14071.4 across 5 years, with a median of $9500.0 in 2021.
  • Biggest five-year swings in Research & Development: plummeted 90.0% in 2022 and later surged 433.33% in 2024.
  • Tracing CVAT's Research & Development over 5 years: stood at $2000.0 in 2021, then crashed by 50.0% to $1000.0 in 2022, then surged by 3500.0% to $36000.0 in 2023, then plummeted by 55.56% to $16000.0 in 2024, then crashed by 75.0% to $4000.0 in 2025.
  • Business Quant data shows Research & Development for CVAT at $4000.0 in Q4 2025, $7000.0 in Q3 2025, and $29000.0 in Q2 2025.